Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
JHEP Reports : Innovation in Hepatology|October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosisLesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.Clinical and Molecular Hepatology|January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.JHEP Reports : Innovation in Hepatology|July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort studyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Journal of Hepatology|January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Gastroenterology|September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral TherapyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 29, 2023
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 StudiesKai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.Hepatology International|July 6, 2020
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George K Lau, et al.JHEP Reports : Innovation in Hepatology|January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆Dongdong Xia, Wei Bai, Qiuhe Wang, et al.Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.Hepatology International|February 17, 2025
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from AsiaAshok Choudhury, Anand V Kulkarni, Vinod Arora, et al.Pageof 8